The global predictive genetic testing and consumer/wellness genomics market is anticipated to witness significant growth, with an expected value of USD 16.35 billion by the year 2030. According to recent market analysis, the market size for predictive genetic testing and consumer/wellness genomics was valued at USD 5.73 billion in 2022, indicating a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 14% over the forecast period from 2023 to 2030.
Predictive genetic testing and consumer/wellness genomics encompass a broad range of genetic testing services and products aimed at providing individuals with insights into their genetic predispositions, ancestry, traits, and potential health risks. Key factors driving the growth of the predictive genetic testing and consumer/wellness genomics market include:
Advancements in Genomic Sequencing Technologies: Continuous advancements in genomic sequencing technologies, including next-generation sequencing (NGS) platforms, microarray analysis, and bioinformatics algorithms, are driving innovation in predictive genetic testing and consumer/wellness genomics, enabling comprehensive genetic profiling and personalized health insights.
Rising Consumer Interest in Personalized Health and Wellbeing: The increasing consumer interest in personalized health and wellbeing, coupled with growing awareness of the role of genetics in disease risk assessment, is driving market growth and demand for predictive genetic testing and consumer/wellness genomics services that empower individuals to make informed decisions about their health.
Expansion of Direct-to-Consumer (DTC) Testing Market: The expansion of the direct-to-consumer (DTC) genetic testing market, fueled by the availability of affordable testing kits, online platforms, and direct-to-consumer marketing strategies, is driving market growth and adoption of consumer-centric genetic testing solutions for ancestry tracing, genetic traits analysis, and health risk assessment.
Integration of Genetic Data with Digital Health Platforms: The integration of genetic data with digital health platforms, wearable devices, and mobile applications is driving market growth and investment in consumer/wellness genomics solutions that offer personalized health recommendations, lifestyle interventions, and disease prevention strategies based on genetic insights.
Regulatory Support and Industry Standards: Supportive regulatory frameworks, industry standards, and quality assurance guidelines for predictive genetic testing and consumer/wellness genomics are driving market growth and fostering consumer confidence in genetic testing services, ensuring data privacy, confidentiality, and ethical use of genetic information.
Research Collaborations and Population Genomics Initiatives: Collaborative research efforts, population genomics initiatives, and large-scale genetic studies are driving market growth and expanding the utility of predictive genetic testing and consumer/wellness genomics in population health management, public health surveillance, and precision medicine initiatives.
KEY MARKET SEGMENTS:
By Test Type
- Predictive Testing
- Consumer Genomics
- Wellness Genomics
By Application
- Breast & Ovarian Cancer
- Cardiovascular Screening
- Diabetic Screening & Monitoring
- Colon Cancer
- Parkinsonism/Alzheimer’s Disease
- Urologic Screening/Prostate Cancer Screening
- Orthopedic & Musculoskeletal
By Setting Type
- Proteomic Testing
- Metabolic Testing
- Genomic Testing
Some of the major key players are Abbott Laboratories, Bio-Rad Laboratories Inc., Counsyl, Inc., Agilent Technologies, Bureau Gravimétrique International, Genesis Genetics, ARUP Laboratories, Hoffmann-La Roche Ltd., Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific, Inc. and Other Players.
As the global healthcare landscape continues to embrace personalized medicine, genomic medicine, and digital health innovations, the predictive genetic testing and consumer/wellness genomics market is expected to witness sustained growth, driven by increasing consumer demand, technological innovation, and expanding applications of genetic testing in healthcare and lifestyle management.
Other Reports You May Like:
Artificial Intelligence In Healthcare Market Size
Blockchain Technology in Healthcare Market Size
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
